Aesculap, Inc., a prominent name in the medical technology sector, is headquartered in the United States and operates extensively across North America. Founded in 1867, Aesculap has established itself as a leader in surgical instruments, sterile processing, and innovative medical solutions, catering primarily to the healthcare industry.
The company is renowned for its high-quality surgical instruments and advanced technologies, which enhance surgical precision and patient safety. Aesculap's commitment to innovation is evident in its diverse product range, including surgical sutures, endoscopic instruments, and custom surgical solutions.
With a strong market position, Aesculap has achieved notable milestones, including numerous industry awards for excellence in product design and functionality. The company continues to set benchmarks in the medical field, driven by a dedication to improving surgical outcomes and patient care.
-19 vs industry average
Aesculap, Inc.’s score of 20 is lower than 37% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Aesculap, Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Motor Vehicle Retail Services has below-average carbon intensity
Industry performance
The Motor Vehicle Retail Services industry has reduced its overall emissions by 38% since 2018
Reported emissions
No reported emissions data is available for Aesculap, Inc. yet.
Aesculap, Inc.'s reported carbon emissions
Aesculap, Inc., headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of B. Braun Melsungen AG, which may influence its climate commitments and emissions reporting.
As of now, Aesculap, Inc. has not established any documented reduction targets or climate pledges. This lack of specific commitments may reflect the broader context of the medical technology industry, where many companies are increasingly focusing on sustainability and carbon reduction initiatives.
Given the absence of direct emissions data and reduction targets, Aesculap, Inc. appears to be in the early stages of formalising its climate strategy. The company may benefit from aligning with industry standards and practices to enhance its environmental performance and transparency in emissions reporting.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Aesculap, Inc.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Aesculap, Inc. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisationsNo peer comparison is available for Aesculap, Inc. yet.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project